MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
Suggest Documents
[A thirteen-week oral repeated dose toxicity study of suplatast tosilate (IPD-1151T) in rats].
[Single dose toxicity studies of suplatast tosilate (IPD-1151T)].
[A fifty-two week oral chronic toxicity study of suplatast tosilate (IPD-1151T) in rats].
[Reproductive and developmental toxicity study of suplatast tosilate (IPD-1151T) (2)--Teratological study in rats by oral administration].
[Reproductive and developmental toxicity study of suplatast tosilate (IPD-1151T) (4)--Perinatal and postnatal study in rats by oral administration].
[Reproductive and developmental toxicity study of suplatast tosilate (IPD-1151T) (3)--Teratological study in rabbits by oral administration].
[Mutagenicity tests of suplatast tosilate (IPD-1151T)].
Four new polymorphic forms of suplatast tosilate.
[Antigenicity tests of suplatast tosilate (IPD-1151T)].
Novel antitussive effect of suplatast tosilate in guinea pigs.
Toxicity evaluation of zinc aluminium levodopa nanocomposite via oral route in repeated dose study.
Repeated dose 28-day oral toxicity study of moniliformin in rats.
[Effect of suplatast tosilate (IPD-1151T) on types I-IV allergic reactions].
[Effects of suplatast tosilate (IPD-1151T) on antibody formations in mice].
Evaluation of 2-week repeated oral dose toxicity of 100 nm zinc oxide nanoparticles in rats.
developmental toxicity and mutagenic potential of 'Calebin A'.
Repeated oral dose tolerance in dogs treated concomitantly with ciclosporin and oclacitinib for three weeks.
Physicochemical analysis and repeated-dose 90-days oral toxicity study of nanocalcium carbonate in Sprague-Dawley rats.
developmental toxicity of 3'-hydroxypterostilbene in experimental animals.
Single-dose oral toxicity of fermented scutellariae radix extract in rats and dogs.
Single- and Repeat-dose Oral Toxicity Studies of Lithospermum erythrorhizon Extract in Dogs.
A 4-week Repeated Dose Toxicity Study of Glycine in Rats by Gavage Administration.
Zinc oxide nanoparticles: a 90-day repeated-dose dermal toxicity study in rats.
Immunotoxicity of silver nanoparticles in an intravenous 28-day repeated-dose toxicity study in rats.
[A thirteen-week oral repeated dose toxicity study of suplatast tosilate (IPD-1151T) in dogs].
A 13-week oral repeated dose toxicity study of suplatast tosilate (IPD-1151T), a new anti-allergic agent, as well as a 5-week recovery study were carr...
2MB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
[A thirteen-week oral repeated dose toxicity study of suplatast tosilate (IPD-1151T) in rats].
[Single dose toxicity studies of suplatast tosilate (IPD-1151T)].
[A fifty-two week oral chronic toxicity study of suplatast tosilate (IPD-1151T) in rats].
[Reproductive and developmental toxicity study of suplatast tosilate (IPD-1151T) (2)--Teratological study in rats by oral administration].
[Reproductive and developmental toxicity study of suplatast tosilate (IPD-1151T) (4)--Perinatal and postnatal study in rats by oral administration].
[Reproductive and developmental toxicity study of suplatast tosilate (IPD-1151T) (3)--Teratological study in rabbits by oral administration].
[Mutagenicity tests of suplatast tosilate (IPD-1151T)].
Four new polymorphic forms of suplatast tosilate.
[Antigenicity tests of suplatast tosilate (IPD-1151T)].
Novel antitussive effect of suplatast tosilate in guinea pigs.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms